U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656454) titled 'A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants' on June 14.
Brief Summary: This study is being done to understand how much of the medicine (CDR132L) enters the bloodstream after injection under the skin compared to injection into a vein in healthy people. This will help us find the best way to give the medicine to people living with heart failure. The study will assess what the body does to the medicine, and how safe it is.
Study Start Date: June 17
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Heart Failure
Interv...